Table 4.
Baseline values (before the beginning of treatment) of the lipid profile parameters and serum lipase in the different studied groups.
| Groups | Cholesterol (mg/dL) | Triglycerides (mg/dL) | Lipase (U/L) |
|---|---|---|---|
| Normal control | 111.92 ± 5.07 | 64.25 ± 3.40 | 514.50 ± 19.80 |
| Diabetic | 161.80 ± 8.35 a | 138.30 ± 8.63 a | 517.55 ± 19.82 |
| Sitagliptin | 160.70 ± 6.55 a | 137.90 ± 7.48 a | 516.70 ± 16.89 |
| Metformin | 160.43 ± 7.54 a | 137.85 ± 8.33 a | 518 ± 19.64 |
| Combined | 159.96 ± 8.19 a | 137.20 ± 8.35 a | 517.30 ± 14.47 |
The data were expressed as mean ± SD (n = 10). a: significantly different when compared to control, using post hoc ANOVA (LSD), p < 0.05.